Rachel Wilson Net Worth

The estimated Net Worth of Rachel Wilson is at least $581 mil dollars as of 1 October 2021. Ms Wilson owns over 16,382 units of R1 RCM stock worth over $231,314 and over the last 4 years she sold RCM stock worth over $0. In addition, she makes $349,678 as Exec. VP y CFO & Treasurer at R1 RCM.

Ms Wilson RCM stock SEC Form 4 insiders trading

Ms has made over 1 trades of the R1 RCM stock since 2021, according to the Form 4 filled with the SEC. Most recently she exercised 16,382 units of RCM stock worth $231,314 on 1 October 2021.

The largest trade she's ever made was exercising 16,382 units of R1 RCM stock on 1 October 2021 worth over $231,314. On average, Ms trades about 8,191 units every 0 days since 2021. As of 1 October 2021 she still owns at least 16,382 units of R1 RCM stock.

You can see the complete history of Ms Wilson stock trades at the bottom of the page.

Ms. Rachel Wilson biography

Rachel Wilson is the Exec. VP, CFO & Treasurer at R1 RCM.

What is the salary of Ms Wilson?

As the Exec. VP y CFO & Treasurer of R1 RCM, the total compensation of Ms Wilson at R1 RCM is $349,678. There are 6 executives at R1 RCM getting paid more, with Joseph Flanagan having the highest compensation of $4,859,860.

How old is Ms Wilson?

Ms Wilson is 48, she's been the Exec. VP y CFO & Treasurer of R1 RCM since . There are 13 older and 2 younger executives at R1 RCM. The oldest executive at R1 RCM Inc. is Michael Feiner, 77, who is the Independent Director.

What's Ms Wilson's mailing address?

Rachel's mailing address filed with the SEC is C/O R1 RCM INC., 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY, UT, 84123.

Insiders trading at R1 RCM

Over the last 8 years, insiders at R1 RCM have traded over $770,079,900 worth of R1 RCM stock and bought 103,238 units worth $1,376,421 . The most active insiders traders include Achi Series Lllptcp Asc Gp,..., Joseph Gerard Flanagan y John B Iii Henneman. On average, R1 RCM executives and independent directors trade stock every 27 days with the average trade being worth of $7,812,780. The most recent stock trade was executed by John M. Sparby on 6 March 2024, trading 10,046 units of RCM stock currently worth $143,959.

What does R1 RCM do?

R1 RCM Inc. is an American revenue cycle management company servicing hospitals, health systems and physician groups across the United States.

Complete history of Ms Wilson stock trades at R1 RCM

R1 RCM executives and stock owners

R1 RCM executives and other stock owners filed with the SEC include:

• Joseph Flanagan,
  President, Chief Executive Officer, Director
• Gary Long,
  Executive Vice President, Chief Commercial Officer
• Joseph Gerard Flanagan,
  Pres, CEO & Director
• Gary S. Long,
  Exec. VP & Chief Commercial Officer
• Richard Evans,
  Senior Vice President, Chief Accounting Officer, Corporate Controller
• Richard B. Evans Jr.,
  Sr. VP, Corp. Controller & Chief Accounting Officer
• Rachel Wilson,
  Exec. VP, CFO & Treasurer
• Alex Mandl,
  Lead Independent Director
• Michael Feiner,
  Independent Director
• Jill Smith,
  Independent Director
• John Henneman,
  Independent Director
• Anthony Tersigni,
  Director
• Anthony Speranzo,
  Independent Director
• Rachel Wilson,
  Chief Financial Officer, Treasurer
• Atif Rahim,
  Senior Vice President - Investor Relations & Business Development
• Vijay Kotte,
  Executive Vice President - Physician Services
• Ian Sacks,
  Independent Director
• Neal Moszkowski,
  Independent Director
• Albert Zimmerli,
  Director
• Vijay Kumar Kotte,
  Exec. VP of Strategy & Corp. Devel. and Chief Solutions Officer
• Sean Radcliffe,
  Exec. VP, Gen. Counsel & Corp. Sec.
• Corey Perman,
  Exec. VP of Compliance & Risk
• Jay Sreedharan,
  Chief Technology & Digital Officer
• John M. Sparby,
  Exec. VP of Operations & Delivery and COO
• Charles J. Ditkoff,
  Director
• Steven J Shulman,
  Director
• Christopher Simon Ricaurte,
  Chief Financial Officer
• Mountain Capital, L.L.C.Coy...,
  
• Pamela L. Spikner,
  Principal Accounting Officer
• Thomas A Lesica,
  Chief Operating Officer
• Bradford Kyle Armbrester,
  Director
• Jeremy Delinsky,
  Director
• David M Dill,
  Director
• Scanlan Agnes Bundy,
  Director
• Lee Rivas,
  Chief Executive Officer
• John M. Sparby,
  President
• Jennifer D. Williams,
  Chief Financial Officer
• Kyle Hicok,
  Chief Commercial Officer